11:12 AM EST, 11/26/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving lower late Tuesday morning, declining 0.37% to 1,317.16 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Cellectis ( CLLS ) , which climbed 14% and 4.6% respectively. They were followed by furniture maker Natuzzi (NTZ) and pharmaceutical company Novo Nordisk ( NVO ) , which rose 4.1% and 1.8% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which fell 8.4% and 2.6% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and medical device maker EDAP TMS ( EDAP ) , which lost 2% each.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company NuCana ( NCNA ) , which increased 6% each. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and cruise line operator Carnival (CUK), which were up 4.7% and 1.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and TC Biopharm ( TCBP ) , which fell 10% and 5.9% respectively. They were followed by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Amarin ( AMRN ) , which were down 4.8% and 2.5% respectively.